病证结合诊疗模式在肝癌患者康复与姑息治疗中的应用
|
摘要
目的探讨病证结合诊疗模式在肝癌患者康复与姑息治疗中的运用。方法选取2016年8月至2018年8月间四川大学华西医院收治的60例肝癌患者,采用随机数字表法分为病症结合诊疗模式组和常规基础诊疗模式组,每组30例。常规基础诊疗模式组患者采用常规基础诊疗模式,病症结合诊疗模式组患者采用病症结合诊疗模式,比较两组患者的临床疗效、瘤体直径和生活质量。结果病症结合诊疗模式组患者的总缓解率为76. 7%,高于常规基础诊疗模式组的60. 0%,两组比较,差异有统计学意义(P <0. 05)。治疗后,两组患者的瘤体直径均缩短,生活质量评分均升高,且病症结合诊疗模式组均优于常规基础诊疗模式组,两组比较,差异均有统计学意义(均P <0. 05)。结论病证结合诊疗模式在肝癌患者康复与姑息治疗中的应用效果较常规基础诊疗模式好,值得临床推广。
Objective To study the application of combination of disease and syndrome diagnosis and treatment mode in rehabilitation and palliative care for liver cancer. Methods Sixty patients with hepatocellular carcinoma who received treatment at West China Hospital,Sichuan University from August 2016 to August 2018 were selected. These patients were randomly divided into combination diagnosis and treatment group and conventional basic diagnosis and treatment group with 30 patients in each group. The combination diagnosis and treatment group was given combination of disease and syndrome diagnosis and treatment mode. The conventional basic diagnosis and treatment group was given conventional basic diagnosis and treatment. Clinical efficacy,tumor diameters,and quality of life were statistically analyzed compared between the two groups. Results The overall remission rate was 76. 7% for the combination diagnosis and treatment group which was significantly higher than 60. 0% of the conventional basic diagnosis and treatment group( P < 0. 05). After the treatment,diameter of tumors was shortened and quality of life score was increased in both groups compared with before the treatment with the combination of disease and syndrome diagnosis and treatment group better than the conventional basic diagnosis and treatment group( all P <0. 05). Conclusion The efficacy of combination of disease and syndrome diagnosis and treatment is better than conventional basic diagnosis and treatment mode in rehabilitation and palliative care for liver cancer.Accordingly it is worthy of promotion in the clinical practice.
Objective To study the application of combination of disease and syndrome diagnosis and treatment mode in rehabilitation and palliative care for liver cancer. Methods Sixty patients with hepatocellular carcinoma who received treatment at West China Hospital,Sichuan University from August 2016 to August 2018 were selected. These patients were randomly divided into combination diagnosis and treatment group and conventional basic diagnosis and treatment group with 30 patients in each group. The combination diagnosis and treatment group was given combination of disease and syndrome diagnosis and treatment mode. The conventional basic diagnosis and treatment group was given conventional basic diagnosis and treatment. Clinical efficacy,tumor diameters,and quality of life were statistically analyzed compared between the two groups. Results The overall remission rate was 76. 7% for the combination diagnosis and treatment group which was significantly higher than 60. 0% of the conventional basic diagnosis and treatment group( P < 0. 05). After the treatment,diameter of tumors was shortened and quality of life score was increased in both groups compared with before the treatment with the combination of disease and syndrome diagnosis and treatment group better than the conventional basic diagnosis and treatment group( all P <0. 05). Conclusion The efficacy of combination of disease and syndrome diagnosis and treatment is better than conventional basic diagnosis and treatment mode in rehabilitation and palliative care for liver cancer.Accordingly it is worthy of promotion in the clinical practice.
引文
[1]王影,庄曾渊.庄曾渊研究员运用“病证结合、分期论治”理论的经验体会[J].中国中医眼科杂志,2016,26:324-326.
[2]刘声,张丽娜,何立丽,等.基于病理分型与中医证型相参的孙桂芝教授诊治肺癌经验探讨[J].世界中西医结合杂志,2012,7:952-954.
[3]陈嘉斌,柴可群,陈淼,等.柴可群辨治结、直肠癌的学术思想及临诊经验探析[J].中华中医药杂志,2015,11:3956-3959.
[4]苏占清.中医病名将走向何处?[J].中国中西医结合杂志,2013,33:726-730.
[5]马捷,李峰,宋月晗,等.中医病证结合理论研究[J].光明中医,2012,27:2172-2173.
[6]林丽珠,肖志伟.中西医结合治疗肿瘤的几点思考[J].中医杂志,2012,53:1554-1556.
[7]张光明,耿平,张学伟,等.近五年国内外中西医结合抗肿瘤的临床研究进展[J].当代医学,2013,19:16-17.
[8]王学谦,龚宏霞,林洪生,等.康艾注射液在肿瘤姑息治疗中的临床研究现状[J].世界中医药,2015,13:1264-1269.
[9] Zimmermann C,Swami N,Krzyzanowska M,et al. Early palliative care for patients with advanced cancer:a cluster-randomised controlled trial[J]. Lancet,2014,383:1721-1730.
[10] DeSantis CE,Lin CC,Mariotto AB,et al. Cancer treatment and survivorship statistics,2014[J]. CA Cancer J Clin,2014,64:252-271.
[11]王皓,王俊杰.促红细胞生成素在肺癌治疗中的作用[J].中国肿瘤临床与康复,2008,15:181-183.
[2]刘声,张丽娜,何立丽,等.基于病理分型与中医证型相参的孙桂芝教授诊治肺癌经验探讨[J].世界中西医结合杂志,2012,7:952-954.
[3]陈嘉斌,柴可群,陈淼,等.柴可群辨治结、直肠癌的学术思想及临诊经验探析[J].中华中医药杂志,2015,11:3956-3959.
[4]苏占清.中医病名将走向何处?[J].中国中西医结合杂志,2013,33:726-730.
[5]马捷,李峰,宋月晗,等.中医病证结合理论研究[J].光明中医,2012,27:2172-2173.
[6]林丽珠,肖志伟.中西医结合治疗肿瘤的几点思考[J].中医杂志,2012,53:1554-1556.
[7]张光明,耿平,张学伟,等.近五年国内外中西医结合抗肿瘤的临床研究进展[J].当代医学,2013,19:16-17.
[8]王学谦,龚宏霞,林洪生,等.康艾注射液在肿瘤姑息治疗中的临床研究现状[J].世界中医药,2015,13:1264-1269.
[9] Zimmermann C,Swami N,Krzyzanowska M,et al. Early palliative care for patients with advanced cancer:a cluster-randomised controlled trial[J]. Lancet,2014,383:1721-1730.
[10] DeSantis CE,Lin CC,Mariotto AB,et al. Cancer treatment and survivorship statistics,2014[J]. CA Cancer J Clin,2014,64:252-271.
[11]王皓,王俊杰.促红细胞生成素在肺癌治疗中的作用[J].中国肿瘤临床与康复,2008,15:181-183.